Alpha Tau Medical(DRTS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

DRTS Alpha Tau Medical

Market Closed 05-15 16:00:00 EDT

10.36

-0.05

-0.48%

盘后10.52

+0.16+1.54%

19:58 EDT

High10.81	Low10.15	Vol901.30K
Open10.26	D1 Closing10.41	Amplitude6.34%
Mkt Cap911.78M	Tradable Cap594.18M	Total Shares88.01M
T/O9.47M	T/O Rate1.57%	Tradable Shares57.35M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"DRTS","market":"US","secType":"STK","nameCN":"Alpha Tau Medical","latestPrice":10.36,"timestamp":1778875200000,"preClose":10.41,"halted":0,"volume":901304,"hourTrading":{"tag":"盘后","latestPrice":10.5195,"preClose":10.36,"latestTime":"19:58 EDT","volume":15545,"amount":163196.4108,"timestamp":1778889507499,"change":0.1595,"changeRate":0.015396,"amplitude":0.041506},"delay":0,"changeRate":-0.004803073967339165,"floatShares":57353100,"shares":88009737,"eps":-0.529999,"marketStatus":"Market Closed","change":-0.05,"latestTime":"05-15 16:00:00 EDT","open":10.26,"high":10.8099,"low":10.15,"amount":9472080.436328,"amplitude":0.063391,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.529999,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1779091200000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":10.41,"preHourTrading":{"tag":"盘前","latestPrice":10.26,"preClose":10.41,"latestTime":"09:29 EDT","volume":9958,"amount":102606.176452,"timestamp":1778851799999,"change":-0.15,"changeRate":-0.014409,"amplitude":0.058598},"postHourTrading":{"tag":"盘后","latestPrice":10.5195,"preClose":10.36,"latestTime":"19:58 EDT","volume":15545,"amount":163196.4108,"timestamp":1778889507499,"change":0.1595,"changeRate":0.015396,"amplitude":0.041506},"volumeRatio":0.5562913563350923,"impliedVol":0.6232,"impliedVolPercentile":0.1894},"requestUrl":"/m/hq/s/DRTS/wiki","defaultTab":"wiki","newsList":[{"id":"2634245345","title":"Alpha Tau price target raised to $14 from $12 at Ladenburg","url":"https://stock-news.laohu8.com/highlight/detail?id=2634245345","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634245345?lang=en_us&edition=fundamental","pubTime":"2026-05-12 23:35","pubTimestamp":1778600138,"startTime":"0","endTime":"0","summary":"Ladenburg raised the firm’s price target on Alpha Tau (DRTS) to $14 from $12 and keeps a Buy rating on the shares after the company announced inter...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alpha-tau-price-target-raised-to-14-from-12-at-ladenburg-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alpha-tau-price-target-raised-to-14-from-12-at-ladenburg-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","DRTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634221199","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: BioNTech SE (BNTX), Personalis (PSNL) and Alpha Tau Medical Ltd (DRTS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2634221199","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634221199?lang=en_us&edition=fundamental","pubTime":"2026-05-12 20:41","pubTimestamp":1778589690,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on BioNTech SE (BNTX), Personalis (PSNL) and Alpha Ta...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-biontech-se-bntx-personalis-psnl-and-alpha-tau-medical-ltd-drts-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-biontech-se-bntx-personalis-psnl-and-alpha-tau-medical-ltd-drts-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSNL","LU0348788117.USD","BK4082","LU2008162690.USD","SG9999002620.SGD","LU0264606111.USD","BK4588","BK4535","LABU","LU2543165471.USD","BK4548","HCSG","BK4085","BK4220","LU0516422366.SGD","LU0516423174.USD","LU0572940350.SGD","LU0345776255.USD","DRTS","LU0572939691.SGD","LU0345775950.USD","LU0589944569.HKD","SG9999001135.SGD","LU2177674079.SGD","LU0261945553.USD","SG9999014484.SGD","LU1839390173.USD","LU0175139822.USD","LU0737861269.HKD","BK4551","BNTX","LU2125910500.SGD","SG9999005177.SGD","BK4554","LU1861217088.USD","SE","LU2065169927.USD","LU2065171402.SGD","XBI","SG9999004360.SGD","BK4581","LU0516422952.EUR","LU1242518931.SGD","LU2065171311.SGD","SG9999013460.SGD","LU0516422440.USD","LU2045819591.USD","LU0048573645.USD","IE0001KFT4U8.USD","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634290758","title":"Alpha Tau Medical Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2634290758","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634290758?lang=en_us&edition=fundamental","pubTime":"2026-05-12 18:44","pubTimestamp":1778582640,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DRTS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 12, 2026 06:44 ET (10:44 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DRTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634297168","title":"Alpha Tau Medical Ltd. : H.c. Wainwright Raises Target Price to $15 From $12","url":"https://stock-news.laohu8.com/highlight/detail?id=2634297168","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634297168?lang=en_us&edition=fundamental","pubTime":"2026-05-12 18:15","pubTimestamp":1778580926,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nAZN4SVPK3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","DRTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634728746","title":"Alpha Tau Medical Shares Interim U.S. Glioblastoma Trial Data for Alpha DaRT","url":"https://stock-news.laohu8.com/highlight/detail?id=2634728746","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634728746?lang=en_us&edition=fundamental","pubTime":"2026-05-11 21:57","pubTimestamp":1778507877,"startTime":"0","endTime":"0","summary":"The latest update is out from Alpha Tau Medical Ltd ( ($DRTS) ). On May 11, 2026, Alpha Tau Medical presented interim clinical data from its U.S. R...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/alpha-tau-medical-shares-interim-u-s-glioblastoma-trial-data-for-alpha-dart?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/alpha-tau-medical-shares-interim-u-s-glioblastoma-trial-data-for-alpha-dart?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","DRTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634289121","title":"Alpha Tau Says Complete Response in 2 Brain Cancer Patients Observed in Interim Trial of Radiation Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2634289121","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634289121?lang=en_us&edition=fundamental","pubTime":"2026-05-11 20:21","pubTimestamp":1778502080,"startTime":"0","endTime":"0","summary":"Alpha Tau Medical  said Monday it released interim data from a US clinical trial evaluating its radiation treatment in three patients with a recurrent form of brain cancer.Two participants achieved a complete response with the disappearance of tumor lesions, while the third showed a 30% reduction in tumor size, the company said.The safety review noted one serious adverse event involving a seizure and temporary paralysis that was subsequently resolved with steroids, it said.Shares of the company were up over 20% in Monday premarket activity.Price: 10.25, Change: +1.74, Percent Change: +20.48","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4082","DRTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634288032","title":"Alpha Tau Alpha DaRT glioblastoma trial shows 67% complete response in interim data","url":"https://stock-news.laohu8.com/highlight/detail?id=2634288032","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634288032?lang=en_us&edition=fundamental","pubTime":"2026-05-11 19:03","pubTimestamp":1778497436,"startTime":"0","endTime":"0","summary":"Alpha Tau Medical reported interim results from its U.S. REGAIN trial of Alpha DaRT in recurrent glioblastoma, based on first three patients treated, with results already analyzed following an FDA-requested safety review.Two patients showed complete disappearance of visible tumor on follow-up imaging, while third patient showed disease stabilization.No local or distant recurrence was seen in these patients as of May 3, 2026.Safety profile was described as favorable, with one treatment-related serious adverse event that resolved.Management plans to discuss the interim findings on a conference call scheduled for 8:30 a.m. ET today.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDLmTVZq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","SG9999014005.SGD","BK4588","BK4082","DRTS","IE00BN0W2V16.EUR","IE00B64PRP62.GBP","IE00BN0W2T93.GBP","SG9999014013.SGD","BK4112","IE00BN0W2W23.USD","BK4585","NDAQ","IE00BKPKM429.USD","SG9999014021.USD","LU2095319765.USD","IE00B3QW5Z07.USD","LU0314104364.USD","IE00BGHQF748.EUR","LU2210150020.SGD","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634466288","title":"Alpha Tau Announces Groundbreaking Interim Results From Its U.S. Alpha Dart® Recurrent Glioblastoma Trial, With 100% Local Disease Control, 67% Complete Response Rate, and Favorable Safety Profile Observed - Conference Call Scheduled for 8:30Am Et","url":"https://stock-news.laohu8.com/highlight/detail?id=2634466288","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634466288?lang=en_us&edition=fundamental","pubTime":"2026-05-11 19:00","pubTimestamp":1778497201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nTUA6XKMPV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DRTS","DRTSW","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634283845","title":"Alpha Tau Medical Ltd - One Associated Grade 3 Serious Adverse Event Was Observed, Since Resolved","url":"https://stock-news.laohu8.com/highlight/detail?id=2634283845","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634283845?lang=en_us&edition=fundamental","pubTime":"2026-05-11 19:00","pubTimestamp":1778497201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nTUA6XKMPV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","DRTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634283824","title":"Alpha Tau Medical Ltd - No Unanticipated Serious Adverse Events Observed as of May 3, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2634283824","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634283824?lang=en_us&edition=fundamental","pubTime":"2026-05-11 19:00","pubTimestamp":1778497201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nTUA6XKMPV:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DRTSW","BK4082","DRTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633513404","title":"Alpha Tau completes enrollment in pivotal ReSTART trial for recurrent skin cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2633513404","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633513404?lang=en_us&edition=fundamental","pubTime":"2026-05-08 21:02","pubTimestamp":1778245348,"startTime":"0","endTime":"0","summary":"Alpha Tau Medical completed enrollment in ReSTART, its first U.S. pivotal trial for Alpha DaRT in recurrent cutaneous squamous cell carcinoma, positioning program to support FDA pre-market approval.Study results have not been presented; trial now moves into follow-up to generate response and durability data.Completion of enrollment marks shift from recruitment to evidence build for potential first U.S. commercial clearance of Alpha DaRT in this indication.Company has already started modular PMA filing, signaling regulatory work is progressing in parallel with clinical readout.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nNDL3y6q8J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","LU2095319765.USD","SG9999014005.SGD","LU2210150020.SGD","BK4585","SG9999014021.USD","BK4112","NDAQ","BK4588","IE00BGHQF748.EUR","LU2210149790.SGD","LU0314104364.USD","SG9999014013.SGD","IE00BKPKM429.USD","SG9999014039.USD","DRTS","IE00BN0W2V16.EUR","IE00B3QW5Z07.USD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633597734","title":"Alpha Tau Completes Patient Enrollment in Its U.S. Pivotal Skin Cancer Study, Advancing Towards Goal of FDA Approval of Alpha Dart® to Treat Recurrent Cutaneous Squamous Cell Carcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2633597734","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633597734?lang=en_us&edition=fundamental","pubTime":"2026-05-08 21:00","pubTimestamp":1778245200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nTUABGBLPN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DRTSW","DRTS","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633672178","title":"Alpha Tau treats first patient with Alpha DaRT in Italy","url":"https://stock-news.laohu8.com/highlight/detail?id=2633672178","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633672178?lang=en_us&edition=fundamental","pubTime":"2026-05-08 02:29","pubTimestamp":1778178584,"startTime":"0","endTime":"0","summary":"Alpha Tau (DRTS) announced the treatment of the first patient in Italy in its feasibility and safety study of intratumoral diffusing alpha-emitter ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alpha-tau-treats-first-patient-with-alpha-dart-in-italy-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alpha-tau-treats-first-patient-with-alpha-dart-in-italy-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","DRTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633714057","title":"Alpha Tau Medical Ltd: Successfully Treats First Pancreatic Cancer Patient in Italy With Alpha Dart","url":"https://stock-news.laohu8.com/highlight/detail?id=2633714057","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633714057?lang=en_us&edition=fundamental","pubTime":"2026-05-07 21:04","pubTimestamp":1778159057,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nFWN41K0YK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DRTS","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633140306","title":"Alpha Tau launches Italy feasibility study of Alpha DaRT in pancreatic cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2633140306","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633140306?lang=en_us&edition=fundamental","pubTime":"2026-05-07 21:01","pubTimestamp":1778158911,"startTime":"0","endTime":"0","summary":"Alpha Tau Medical reported first pancreatic cancer patient in Italy treated with Alpha DaRT at University of Verona Pancreas Institute under feasibility and safety study Protocol CTP-PANC-03; no trial results were presented.Procedure was described as successful, supporting continued clinical development of Alpha DaRT as local intervention for locally advanced, inoperable pancreatic cancer.Protocol allows both endoscopic ultrasound-guided placement and percutaneous placement of Alpha DaRT sources, widening potential clinical use beyond endoscopy-only access.Italy study adds to expanding pancreatic program alongside ongoing IMPACT trial in US and ACAPELLA trial in France, positioning company for broader multicenter evidence generation.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDL24t68T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","IE00BN0W2T93.GBP","SG9999014013.SGD","BK4588","SG9999014021.USD","BK4585","IE00BKPKM429.USD","BK4112","DRTS","IE00B64PRP62.GBP","IE00BGHQF748.EUR","LU2210150020.SGD","IE00BN0W2W23.USD","LU2095319765.USD","IE00B3QW5Z07.USD","NDAQ","BK4082","LU2210149790.SGD","IE00BN0W2V16.EUR","SG9999014039.USD","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633458509","title":"Alpha Tau to present Alpha DaRT-pembrolizumab head and neck cancer trial data at AHNS 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2633458509","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633458509?lang=en_us&edition=fundamental","pubTime":"2026-05-05 21:05","pubTimestamp":1777986341,"startTime":"0","endTime":"0","summary":"Alpha Tau Medical announced podium presentation of complete top-line results from study testing Alpha DaRT in combination with pembrolizumab in elderly patients with locally advanced or metastatic head and neck squamous cell carcinoma.Data were previously shown in interim form at R&D Day in January 2025, with full results scheduled for AHNS 12th International Conference on Head and Neck Cancer in Boston on July 21, 2026.Update supports strategy to pair localized intratumoral radiotherapy with checkpoint immunotherapy, targeting patients who often cannot tolerate standard aggressive regimens.Company highlighted safety profile across prior head and neck studies, positioning combination approach as a potential add-on that does not disrupt ongoing systemic immunotherapy.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purpose","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260505:nNDLbdhFKV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DRTS","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632594519","title":"Alpha Tau presents updated results from two clinical trials of Alpha DaRT","url":"https://stock-news.laohu8.com/highlight/detail?id=2632594519","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632594519?lang=en_us&edition=fundamental","pubTime":"2026-05-04 22:13","pubTimestamp":1777904000,"startTime":"0","endTime":"0","summary":"Alpha Tau (DRTS) announced the presentation of updated pooled results from two first-in-human clinical trials of Alpha DaRT in pancreatic ductal ad...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alpha-tau-presents-updated-results-from-two-clinical-trials-of-alpha-dart-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alpha-tau-presents-updated-results-from-two-clinical-trials-of-alpha-dart-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["DRTS","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632955098","title":"Alpha Tau Announces 100% Local Disease Control Rate and Favorable Safety Profile Observed in Alpha Dart® Pancreatic Cancer Trials Presented at Ddw 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2632955098","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632955098?lang=en_us&edition=fundamental","pubTime":"2026-05-04 21:17","pubTimestamp":1777900641,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nTUA4ZLGJ9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DRTS","BK4082","DRTSW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632955681","title":"Alpha Tau reports 100% local disease control in pooled Alpha DaRT pancreatic trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2632955681","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2632955681?lang=en_us&edition=fundamental","pubTime":"2026-05-04 21:01","pubTimestamp":1777899688,"startTime":"0","endTime":"0","summary":"Alpha Tau Medical reported updated pooled results from two first-in-human pancreatic cancer trials that were presented at Digestive Disease Week 2026.Treated patients achieved local disease control, supporting an efficacy signal in a setting with limited treatment options.Safety profile was described as favorable, with few device-related adverse events that largely resolved quickly.Procedure uses outpatient endoscopic ultrasound delivery, positioning Alpha DaRT for integration into routine GI endoscopy workflows.Data were framed as supporting continued development, including advancement of its ongoing U.S. multicenter pancreatic cancer IMPACT trial.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alpha Tau Medical Ltd. published the ori","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260504:nNDL2jBJDf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","DRTS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630370958","title":"BRIEF-Alpha Tau Medical Files To Offer Up To $300 Million In Securities - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2630370958","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630370958?lang=en_us&edition=fundamental","pubTime":"2026-04-28 18:27","pubTimestamp":1777372036,"startTime":"0","endTime":"0","summary":"BRIEF-Alpha Tau Medical Files To Offer Up To $300 Million In Securities - SEC FilingApril 28  - SEC Filing:ALPHA TAU MEDICAL LTD - FILES TO OFFER UP TO $300 MILLION IN SECURITIES - SEC FILINGALPHA TAU MEDICAL LTD - MAY SELL UP TO $100 MILLION ORDINARY SHARES UNDER EQUITY DISTRIBUTION AGREEMENT - SEC FILINGSource text: [ID:n0001213900-26-048160]Further company coverage: DRTS.O ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nFWN41B0ES:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DRTS","BK4082"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.alphatau.com","stockEarnings":[{"period":"1week","weight":0.2174},{"period":"1month","weight":0.3147},{"period":"3month","weight":0.4369},{"period":"6month","weight":1.7894},{"period":"1year","weight":2.5012},{"period":"ytd","weight":1.0929}],"compareEarnings":[{"period":"1week","weight":0.0021},{"period":"1month","weight":0.056},{"period":"3month","weight":0.0842},{"period":"6month","weight":0.1001},{"period":"1year","weight":0.2519},{"period":"ytd","weight":0.084}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. Alpha Tau Medical Ltd. was incorporated in 2015 and is headquartered in Jerusalem, Israel.","yearOnYearQuotes":[{"month":1,"riseRate":1,"avgChangeRate":0.237533},{"month":2,"riseRate":0.25,"avgChangeRate":-0.092011},{"month":3,"riseRate":0,"avgChangeRate":-0.091558},{"month":4,"riseRate":0.6,"avgChangeRate":-0.032951},{"month":5,"riseRate":0.8,"avgChangeRate":0.123612},{"month":6,"riseRate":1,"avgChangeRate":0.079508},{"month":7,"riseRate":0.25,"avgChangeRate":-0.00683},{"month":8,"riseRate":0.5,"avgChangeRate":-0.059828},{"month":9,"riseRate":0.5,"avgChangeRate":0.052507},{"month":10,"riseRate":0,"avgChangeRate":-0.106065},{"month":11,"riseRate":0.25,"avgChangeRate":0.002718},{"month":12,"riseRate":0.5,"avgChangeRate":0.017167}],"exchange":"NASDAQ","name":"Alpha Tau Medical","nameEN":"Alpha Tau Medical"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Alpha Tau Medical(DRTS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Alpha Tau Medical(DRTS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Alpha Tau Medical,DRTS,Alpha Tau Medical股票,Alpha Tau Medical股票老虎,Alpha Tau Medical股票老虎国际,Alpha Tau Medical行情,Alpha Tau Medical股票行情,Alpha Tau Medical股价,Alpha Tau Medical股市,Alpha Tau Medical股票价格,Alpha Tau Medical股票交易,Alpha Tau Medical股票购买,Alpha Tau Medical股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Alpha Tau Medical(DRTS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Alpha Tau Medical(DRTS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction